Standard Biotools Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 46.4% | 44.8% | 46.9% | 50.0% | 50.8% | 48.5% | 46.8% | 48.6% | 45.4% | 41.8% | 43.6% | 45.5% | 47.0% | 44.9% | 40.4% | 41.1% | 36.5% | 41.2% | 41.9% | 47.1% | 52.0% | 47.1% | 53.8% | 76.4% | 64.0% | 58.7% | 51.1% | 50.8% | 56.0% | 52.6% | 46.9% | 53.9% | 48.3% | 53.1% | 45.4% | 51.2% | 51.5% | 57.0% | 46.5% | 47.6% | 50.9% | |
| 53.6% | 55.2% | 53.1% | 50.0% | 49.2% | 51.5% | 53.2% | 51.4% | 54.6% | 58.2% | 56.4% | 54.5% | 53.0% | 55.1% | 59.6% | 58.9% | 63.5% | 58.8% | 58.1% | 52.9% | 48.0% | 52.9% | 46.2% | 23.6% | 36.0% | 41.3% | 48.9% | 49.2% | 44.0% | 47.4% | 53.1% | 46.1% | 51.7% | 46.9% | 54.6% | 48.8% | 48.5% | 43.0% | 53.5% | 52.4% | 49.1% | |
| 41.7% | 35.0% | 33.4% | 31.2% | 31.0% | 25.8% | 28.7% | 27.9% | 25.7% | 24.6% | 27.8% | 27.9% | 26.9% | 25.5% | 31.5% | 32.4% | 20.4% | 25.1% | 32.8% | 30.4% | 32.3% | 22.3% | 33.4% | 67.1% | 33.1% | 31.0% | 25.6% | 22.4% | 25.1% | 24.5% | 35.1% | 32.2% | 29.3% | 30.1% | 26.9% | 28.6% | 32.5% | 32.7% | 10.0% | 9.8% | 21.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 84.2% | 78.2% | 84.5% | 60.0% | 116.5% | 161.8% | 115.4% | 88.5% | 88.8% | 81.7% | 87.9% | 75.8% | 103.1% | 167.5% | 76.5% | 80.5% | 191.4% | 129.1% | 136.0% | 106.5% | 88.0% | 81.5% | 102.8% | |
| 136.9% | 125.7% | 121.8% | 118.9% | 112.3% | 83.0% | 103.2% | 99.8% | 94.8% | 92.6% | 103.6% | 106.4% | 105.1% | 83.4% | 113.7% | 111.5% | 77.2% | 96.7% | 117.0% | 108.6% | 116.8% | 82.3% | 149.9% | 229.0% | 149.1% | 119.5% | 114.9% | 112.2% | 127.4% | 123.3% | 185.3% | 180.7% | 122.3% | 117.1% | 174.4% | 157.7% | 168.5% | 135.2% | 98.0% | 178.7% | 143.9% | |
| -83.3% | -70.6% | -68.7% | -68.9% | -63.0% | -31.5% | -50.0% | -48.4% | -40.1% | -34.4% | -47.2% | -51.9% | -52.1% | -28.3% | -54.1% | -52.7% | -13.7% | -37.9% | -58.9% | -55.7% | -68.8% | -29.4% | -103.8% | -205.4% | -113.2% | -78.1% | -66.1% | -63.1% | -83.5% | -75.9% | -132.2% | -134.5% | -70.5% | -70.2% | -119.7% | -108.9% | -120.0% | -92.1% | -44.5% | -126.3% | -94.8% | |
| 6.6% | 5.8% | 5.7% | 6.1% | 5.9% | 5.3% | 7.5% | 14.8% | 13.9% | 12.6% | 9.0% | 1.7% | 1.7% | 2.0% | 3.3% | 3.4% | 2.2% | 2.0% | 2.7% | 2.9% | 3.4% | 2.8% | 3.9% | 5.7% | 4.1% | 4.4% | 4.4% | 4.1% | 4.8% | 3.9% | 2.3% | 3.8% | – | 7.1% | 0.0% | 0.0% | 0.1% | 0.0% | – | – | – | |
| -90.6% | -78.9% | -74.3% | -74.3% | -67.4% | -37.4% | -57.2% | -62.2% | -53.6% | -46.5% | -84.4% | -52.8% | -53.0% | -38.0% | -60.3% | -54.3% | -15.7% | -38.2% | -62.5% | -56.9% | -53.6% | -26.8% | -290.0% | -347.0% | -117.5% | -76.9% | -66.0% | -60.5% | -82.6% | -70.7% | -70.3% | -113.0% | -59.6% | -72.3% | -116.2% | -84.0% | -168.3% | -92.6% | -69.1% | -106.6% | -107.5% | |
| -1.4% | -8.4% | -7.0% | -3.5% | -3.0% | 0.3% | -4.7% | -0.8% | -2.7% | -0.7% | 0.1% | -4.1% | -4.4% | 1.1% | -2.5% | -4.4% | -0.6% | 2.2% | -5.1% | -1.7% | -5.0% | -2.1% | -2.2% | -8.6% | -2.8% | 0.3% | 1.0% | 1.1% | 0.2% | -0.6% | 0.3% | 0.2% | 0.3% | 0.6% | -0.6% | -2.8% | -6.2% | -151.0% | 0.1% | 0.4% | -43.8% | |
| -89.2% | -70.6% | -67.4% | -70.8% | -64.4% | -37.7% | -52.5% | -61.5% | -50.9% | -45.7% | -84.6% | -48.8% | -48.6% | -39.1% | -57.9% | -49.9% | -15.0% | -40.4% | -57.4% | -55.3% | -48.6% | -24.6% | -287.8% | -338.4% | -114.7% | -77.1% | -67.1% | -61.6% | -82.8% | -70.2% | -70.6% | -203.3% | -59.9% | -72.9% | -128.7% | -153.7% | -177.4% | 81.0% | -213.9% | -133.1% | -103.3% | |
| -63.6% | -54.9% | -50.0% | -47.5% | -43.2% | -16.3% | -30.7% | -33.2% | -36.6% | -20.7% | -62.2% | -37.0% | -36.5% | -23.9% | -42.4% | -36.0% | -3.5% | -27.2% | -47.8% | -41.5% | -36.6% | -13.8% | -271.1% | -320.9% | -99.4% | -59.1% | -46.9% | -41.8% | -53.3% | -53.0% | -56.7% | -92.0% | -45.5% | -55.7% | -95.5% | -74.8% | -160.1% | -87.2% | -62.5% | -132.6% | -108.6% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.